Adverse reactions have been commonly gentle to average in intensity. In all controlled scientific studies, the discontinuation charge due to adverse reactions was 12% for patients receiving pregabalin and 5% for individuals getting placebo. The most common adverse reactions leading to discontinuation from pregabalin treatment groups have been dizzi